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Asthma and Respiratory Irritants (Ozone)
by Frances Silverman*
Asthmatics appear to be more susceptible to the effects ofair pollutants than nonasthmatics. The present
studies were undertaken to examine the effects ofexposing asthmatics to ozone concentrations that occur
in the environment. Seventeen well-documented male and female asthmatics have been exposed for 2 hr in
an environmental chamber to 0.25 ppm of ozone on one occasion (ozone) and to air on another occasion
(air). Effects were assessed by measurements of pulmonary function obtained prior to (O hr), every
half-hour during and at the end of all exposures (2 hr). Paired t-test analysis of lung volumes, forced
expiratory volume in I sec (FEV, ,), and maximum expiratory flow rates at 50%rof vital capacity (V C),)
showed no significant changes (p > 0.05) when the following comparisons were made: 0 hr air vs 0 hr
ozone, 0 hr air vs. 2 hr air, 0 hr ozone vs. 2 hr ozone, 2 hr air vs. 2 hr ozone. There was variability in
severity ofasthma and pulmonary function status; most subjects were taking some form ofmedication at
the time ofstudy. Some asthmatics showed no change or improvement with both air and ozone and others
developed greater reductions in pulmonary function with ozone than with air. Approximately one-third of
the asthmatics demonstrated greater changes inV% w,(. with exposure to0.25 ppm ofozone relative to air
exposure. These studies indicate that acute exposures to ozone at realistic concentrations in the environ-
ment can produce adverse responses in some asthmatics.
Introduction
Air pollution has been associated with an in-
creased incidence of asthma (/-9) and other respi-
ratory diseases (10-16). Ozone, the major portion of
oxidant in photochemical smog, can produce
symptoms and physiologic changes in the lung when
inhaled at concentrations occurring in the environ-
ment. Ozone-induced symptomatology includes
cough, substernal soreness, pharyngitis, and scme
wheeze and dyspnea, indicating irritation of the
respiratory tract (17, 24). Changes in measures of
lung function (17-27) include increases in pulmo-
nary and airway resistance, residual volume and
"'closing volume"; reductions in vital capacity,
forced expiratory volume in 1 sec (FEV.o),
maximum expiratory flow rates, maximum static
elastic recoil pressure ofthe lung, diffusing capacity
and fractional uptake of the lung for carbon
monoxide. Ozone exposure may stimulate irritant
receptors and increase resistance in large and small
airways ofthe lung (17, 18, 21). There is evidence to
suggest that 2 hr exposure to 0.1 ppm of ozone sig-
nificantly decreases arterial partial pressure of oxy-
gen and increases airway resistance in healthy male
volunteers (28).
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Studies in Los Angeles have shown an increased
incidence of asthmatic attacks (5) on days when
oxidant levels exceeded 0.25 ppm. Asthma is
characterized by irritable airways leading one to
expect that asthmatics may be abnormally sensitive
to an irritant like ozone and therefore demonstrate a
lower threshold or more severe responses to ozone
than nonasthmatics. The present study was de-
signed to examine the response ofwell documented
asthmatics, under good control for their disease, to
0.25 ppm of ozone.
Methods
Subjects
The subjects were 17 nonsmoking asthmatics (5
men, 12 women) selected from The Gage Research
Institute Asthma Clinic patient population. These
patients were comprehensively documented with
respect to history, physical examination,
biochemistry, serology, radiology, sputum analysis,
urinalysis, allergy skin tests, pulmonary function
status, and therapy, according to a uniform
documentation protocol. The subjects were under
good control for their asthma at the time of study
and were not withdrawn from their routine medica-
tion regimens. They gave fully informed consent.
All the subjects had diagnosed asthma apparently
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ease. The asthma diagnosis was based on a history
consistent with intermittent diffuse airways obstruc-
tion, pulmonary function tests showing reversible
airways obstruction as demonstrated by an increase
of 15% or more above the baseline value ofat least
one test of airway obstruction following four puffs
of the bronchodilator salbutamol.
Exposure Technique
The exposure chamber and methods ofgenerating
and monitoring ozone have been described previ-
ously (23), except that ozone concentrations were
measured by the chemiluminescence technique
using the Bendix Ozone Analyzer. Each subject
was exposed at least twice, once to filtered air for 2
hr (air) and once to 0.25 ppm of ozone for 2 hr
(ozone). During both exposure periods, the subjects
were seated quietly at rest.
Pulmonary Function Measurements
Lung volumes (functional residual capacity,
FRC; vital capacity, VC; residual volume, RV; total
lung capacity, TLC), maximum expiratory flow-
volume (MEFV) curves, minute ventilation, tidal
volume and respiratory frequency were obtained
prior to the beginning of each exposure. Sub-
sequently, MEFV curves and ventilations were re-
peated at 30-min intervals (0.5 hr, 1 hr, 1.5 hr, and 2
hr), and at the end of the 2-hr exposure lung vol-
umes were repeated as well.
Lung volume (BTPS) was determined by a stan-
dard helium dilution technique using a Collins mod-
ular lung analyzer. MEFV curves were obtained by
displaying the volume and flow signals from a
wedge spirometer (Med-Science Electronics) on the
X and Y axes of a Tektronix (R5103N) storage os-
cilloscope. An electronic timer was started au-
tomatically at the beginning ofexpiratory flow; this
circuit interrupted the oscilloscope display briefly
after an elapsed time of 1 sec. The following were
derived from the MEFV curve: forced vital capacity
(FVC), forced expiratory volume in 1 sec (FEV,0),
maximum expiratory flows at 50% of vital capacity
(V5O%v(,), and 25% of vital capacity (V25%VC') mea-
sured, respectively, at 50% and 25% of the vital
capacity for the specific curve; maximum expira-
tory flow at 60% oftotal lung capacity was obtained
as well at zero time and 2 hr. Subjects breathed
through a modified Otis-McKerrow valve con-
nected on the inspiratory side to a Parkinson-
Cowan dry gas-meter equipped with a recording
potentiometer, and the resulting volumes were re-
corded on a graphic recorder (HP 7745A).
Statistical Analysis
Data for each test obtained at 0.5, 1.0, 1.5 and 2.0
hr air exposure were compared with the 0 hr values
by the Student paired t-test. The same comparison
was made for the ozone exposure data. Similarly
differences between air and ozone exposure data at
each half-hour were assessed by the Student paired
t-test. Chi-square analysis was performed on the
number of decreases in V50%V(C of greater than 10%
with air exposure as compared with the number of
decreases with ozone exposure. There were 66 test
points each with air and ozone.
Results
Physical and clinical characteristics of the asth-
matics are shown in Table 1. There were 5 males
and 12 females. The mean age was 41 years, and the
ages ranged from 20 to 71 years. The mean duration
ofasthma was 16 years but ranged from I year to 48
years prior to the subjects undertaking our study.
Five subjects had cough and sputum and two re-
ported cough only. Seven subjects were former
smokers and none were current cigarette smokers.
Thirteen ofthe 17 subjects had significant + ve skin
test responses to one or more of the common in-
haled allergens.
The objective was to study asthmatics irrespec-
tive of the severity of their disease under the best
degree of control which could be achieved, that is,
in the condition in which they live and work. They
were not withdrawn from their routine medication
regimens. Table 2 indicates the medications the pa-
tients were taking at the time of study. Twelve sub-
Table 1. Physical and clinical characteristics of asthmatics.a
Number Ratio Duration Cough Number of
of male/ Height, Weight, Age, of asthma, and former
asthmatics female cm kg yr yr sputumb smokers
17 5/12 166 63 41 16 7 7
(153-186) (53-81) (20-71) (1-48)
a Values are mean and range in parentheses.
b Number of asthmatics reporting cough or cough and sputum.
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cholidator, nine ofthese and one other patient used
oral broncholidators. Four were on oral steroid
therapy. Five were using the inhaled steroid bec-
lomethasone dipropionate and five were on Intal. In
general these were mild asthmatics or moderately
severe asthmatics whose condition was under good
control.
Table 3 shows the baseline pulmonary function
data obtained from these patients. Mean values ex-
pressed as percentage of predicted (29, 30) are
within normal limits, but, the ranges shown beneath
are indicative of the variability in pulmonary func-
tion status ofthese patients and reflect the obstruc-
tive nature of their disease as does the low mean
FEV,.O/FVC ratio. There is variability in severity of
asthma in these patients, as reflected by the func-
tional capacity of their lungs.
Table 4 shows the results obtained from 2 hr ex-
posure to 0.25 ppm of ozone of the subjects de-
scribed above. There were no dramatic changes as a
result ofeither air exposure or ozone exposure. No
statistically significant differences were demon-
strated by the following paired t-test comparisons of
Table 2. Medications.
Number of
Medication subjectsa
Inhaled bronchodilator 12
Oral bronchodilator 10
Oral steroid 4
Inhaled steroid 5
Intal 5
a Number ofsubjects out ofa total of 17 using indicated medi-
cations at the time of ozone studies.
the data: 0 hr air vs. 0 hr ozone, 0 hr air vs. 2 hr air,
0 hr ozone vs. 2 hr ozone, 2 hr air vs. 2 hr ozone.
Similarly there were no significant ozone induced
changes at any time during exposure compared with
corresponding air exposure or pre-ozone exposure
data in the group as a whole.
Examination ofdata on individuals suggested that
some asthmatics do appear to respond to ozone ex-
posure with a deterioration in lung function. To
identify individuals who may have demonstrated a
response to ozone, we used a range of + 10% ofthe
pre-exposure value on each exposure for 'V50, v.
V50, vc is a measurement we have found to be sensi-
tive and useful for detecting objective changes in
lung function in previous experiments on normals
with ozone exposure (24). Figure 1 shows individual
data obtained at each half hour of air exposure and
ozone exposure. The horizontal lines indicate ±
10% of the pre-exposure value. With air exposure,
there were nine test points for which V50, vc was
greater than 110% ofthe pre-exposure value. There
were eight test points where V50" VC was less than
90%o of the 0 hour value. During ozone exposure,
there were 10 increases of greater than 10% with
ozone and 25 test points where V50 vc was less than
90%. Using chi-square analysis, there were a statis-
tically significantly,greater number of decreases of
more than 10% in V50% VC with ozone (n = 25) than
with air (n = 8). The data suggest that there are
asthmatics who respond to 0.25 ppm of ozone as
compared with their responses to parallel air expo-
sures.
Figure 2 shows mean dataforV50% vc expressed as
percent ofthe zero time value. There was no signifi-
cant difference between air exposure and ozone ex-
Table 3. Routine pulmonary function measurements.a
RV/TLC, VC VC FEV,.O/FVC,
RV % R F FEV1.0 % V505 vc
Mean 111 33 103 102 80 64 63
Range 81-182 19-49 72-120 57-131 23-119 34-92 9-122
a Values % predicted except RV/TLC and FEV1,0/FVC; n = 17.
Table 4. Results of exposures of asthmatics to ozone (0.25 ppm).a
0 hPb 2 hr, % of zero time valuec
Parameter Air Ozone Air Ozone
FVC 3.89 0.25 3.75 0.27 99 ± 3 99 ± 2
FEV1.0 2.65 ± 0.25 2.60 ± 0.27 99 ± 3 95 ± 3
Vsw" vc 2.0 ±0.29 1.96 0.28 102 ± 4 95 ± 5
V60% TLC 1.65 0.31 1.59 0.30 96 ± 5 90 ± 8
RV 1.85 0.16 1.66 0.12 96 4 112 ± 8
a Values are mean ± S.E. n = 17.
b Values at zero time expressed in liters for FVC, FEV.O, and RV and 1./sec for V50/ vc and V60>! TLc.
c Value after 2 hr exposure expressed as percentage of pre-exposure value.
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FIGURE 1. /50,%/ Ve as a percentage ofvalues at zero time against time: (@) individual data obtained during air exposure on 16 subjects at
0.5 hr, 1.0 hr, 1.5 hr and 2.0 hr and for one subject at 1.0 hr and 2.0 hr; (X) corresponding data during ozone exposure. Horizontal
lines represent + 10%o ofzero time value in each case. Significant difference (p < 0.05) between airexposure values ofless than 90%o
(8) and ozone exposure values less than 90%o (25) by chi-square analysis.
GROUP I GROUP 11
(n=17) , (n= 11)
GROUP III
(n= 6)
0.5 1.0 1.5 2.0 05 1.0 1.5 2.0 0.5 1.0 1.5 2.0
TIME (HR.)
FIGURE 2. V50% VC expressed as percentage of values at zero time as a function of time of exposure: (S) mean ± S. E. of air values
obtained at 0.5 hr, 1.0 hr, 1.5 hr, and 2.0 hr ofair exposure; (X) mean ± S. E. ofcorresponding data for ozone exposure. Group I
(n = 17 subjects); group II, 11 subjects who showed no greater decreases (>109o) on ozone than air; Group III, 6 subjects who had
more decreases (>10Wo) on ozone than air.
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,posure for the group as a whole (group I) although
the ozone values are consistently lower than the air
values. In group II, made up ofindividuals who had
no greater responses to ozone than air, the mean
V50. 1( did not change appreciably in ozone or air.
Group III consists of individuals who appeared to
have more functional change in ozone than air.
There was a mean reduction of V150 VC of approxi-
mately 7% after 1 hr of air exposure, and by 2 hr
V50,, VC had returned to 98% of the pre-exposure
value. However with I hr of ozone exposure there
was a mean decrease inVf/50 v(. of22%, and by 2 hr it
was approximately 30%. Four subjects in group III
had symptoms with ozone exposure ranging from
trace to moderately severe cough, shortness of
breath, wheeze and chest tightness; two subjects
had no symptoms. Of the subjects in group II, four
had only trace or mild symptoms and seven had no
symptoms. Two subjects (one in group II and one in
group III) had trace to moderately severe symptoms
with exposure to air.
Discussion
The present studies were carried out to examine
whether acute exposure of asthmatics to a realistic
environmental concentration of an irritant pollu-
tant, ozone, can result in any detectable changes in
lung function. The asthmatics had varying degrees
ofseverity ofasthma; most were taking medications
for their therapy. The results indicate that although
there was a trend for V"0I VC to fall during ozone
exposure, the difference from that in air was not
statistically significant. However, the results of the
individual subjects demonstrated a drop in /50,, v(. in
six subjects on ozone compared with air while in the
remaining 11 subjects it did not change appreciably.
Linn et al. (31) have recently reported on studies
ofexposure ofasthmatics to 0.2 ppm ofozone with
secondary stresses ofheat and exercise. They found
no significant changes in pulmonary function. They
did observe small but significant blood biochemical
changes which included: increased glucose-6-
phosphate dehydrogenase and lactate dehy-
drogenase activities; increased red cell fragility and
decreased concentration of reduced glutathione,
hemoglobin concentration and acetylcholinesterase
activity. Our results agree with those of Linn et al.
in that no dramatic effects were demonstrated in the
group of asthmatics with 2 hr exposure to ozone.
Linn et al. (31) did not demonstrate any clear excess
ofeffect in individuals with ozone as compared with
control studies. The results of the present studies
indicate that some individuals do respond to 0.25
ppm of ozone over a 2-hr exposure period.
As a result of previous studies of healthy or
mildly asthmatic persons, Hackney et al. (32, 33)
suggested that prior ambient exposures elicit an
adaptive response decreasing the subjects reactivity
to ozone. The asthmatics in Linn's studies (31) all
lived in urban southern California and had been ex-
posed to ozone on occasion. The subjects in the
present study live in Toronto, Canada, where expo-
sures to ozone are to lower concentrations and
much less frequent.
In terms of relating response to ozone with his-
torical and clinical features of asthma in these sub-
jects, no relationship was seen between response to
ozone and the following parameters: (1) pulmonary
function status prior to exposure, (2) duration of
asthma, (3) cough and sputum, (4) allergies. Five of
six subjects who appeared to respond were taking
Intal and none ofthe others were; five were former
smokers, and only two ofthose who did not appear
to respond to ozone were ex-smokers.
It is concluded from these studies that individual
asthmatics can demonstrate deterioration in objec-
tive measures of lung function at 0.25 ppm. From
the point ofview ofenvironmental health standards,
it is important to note that higher concentrations of
ozone do occur in and around urban environments
and may have adverse effects on some people suf-
fering from asthma. Additional studies are required
to examine whether the asthmatics who appear to
respond are a subgroup ofa larger group thought to
have increased sensitivity and to establish whether
these people have any unique characteristics which
increase their response to ozone.
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